|
LRPPRC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.044600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.378600E-04 |
| Normal-vs-Stage2 |
1.868410E-01 |
| Normal-vs-Stage3 |
7.5475000000047E-05 |
| Normal-vs-Stage4 |
4.778200E-03 |
| Stage1-vs-Stage2 |
1.065230E-01 |
| Stage1-vs-Stage3 |
5.406200E-01 |
| Stage1-vs-Stage4 |
9.311800E-01 |
| Stage2-vs-Stage3 |
8.408400E-02 |
| Stage2-vs-Stage4 |
2.553200E-01 |
| Stage3-vs-Stage4 |
6.041800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01309999999788E-05 |
| Normal-vs-AfricanAmerican |
1.130960E-01 |
| Normal-vs-Asian |
3.049900E-02 |
| Caucasian-vs-AfricanAmerican |
1.772570E-01 |
| Caucasian-vs-Asian |
2.285800E-01 |
| AfricanAmerican-vs-Asian |
7.329800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.64399999999754E-05 |
| Normal-vs-Female |
9.957900E-04 |
| Male-vs-Female |
2.861200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.544270E-03 |
| Normal-vs-Age(41-60Yrs) |
4.88549999999588E-06 |
| Normal-vs-Age(61-80Yrs) |
3.731600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.192080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.125800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.551000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.576200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.936200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.015800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.433800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.089600E-01 |
| Classical-VS-Follicular |
6.934000E-01 |
| Classical-VS-Other |
1.789160E-01 |
| Classical-VS-Normal |
3.392100E-04 |
| Tall-VS-Follicular |
9.377800E-01 |
| Tall-VS-Other |
1.387630E-01 |
| Tall-VS-Normal |
1.998000E-02 |
| Follicular-VS-Other |
2.760800E-01 |
| Follicular-VS-Normal |
1.597750E-02 |
| Other-VS-Normal |
5.421400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.601070E-04 |
| Normal-vs-N1 |
8.07959999999941E-05 |
| N0-vs-N1 |
2.340800E-01 |
|
|
